Planet Briefing

First published · Last updated

P2.06.10 Title: Prognostic Impact of TP53 Co-Mutations with EGFR vs KRAS in Advanced Non-Small Cell Lung Cancer: A cBioPortal Analysis

A journal article reports an analysis using cBioPortal to compare how TP53 co-mutations alongside EGFR versus KRAS relate to prognosis in advanced non-small cell lung cancer. The excerpt lists Elsevier BV as publisher and identifies the item as a journal article published 2025-10-01.

EGFR-dependent and independent resistance mechanisms in EGFR-mutated non-small cell lung cancer (NSCLC).
Illustrative image: EGFR-dependent and independent resistance mechanisms in EGFR-mutated non-small cell lung cancer (NSCLC). — Kedrex/Wikimedia Commons, CC BY 4.0

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
6/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
6/10
Urgency
2/10

Why it matters

The study addresses prognostic biomarkers relevant to advanced non-small cell lung cancer.

Sources

Report an issue